Ads
related to: MRNA Stock
Search results
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 3 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
Moderna (NASDAQ:MRNA) Upgraded to Hold by Evercore ISI
ETF DAILY NEWS· 2 days agoEvercore ISI upgraded shares of Moderna (NASDAQ:MRNA – Free Report) to a hold rating in a research note released on Monday, Zacks.com reports. Canaccord Genuity Group lifted ...
Maravai (MRVI) Advances in RNA Research With New Collaboration
Zacks via Yahoo Finance· 8 hours agoUnder the latest collaboration, TriLink’s commitment includes providing both direct funding and...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters· 5 hours agoModerna said on Friday the European Patent Office had upheld the validity of one of the company's...
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoThis includes an assessment of its current market status and performance. Present Market Standing of Moderna Currently trading with a volume of 1,671,221, the MRNA's price ...
10 Health Care Stocks Whale Activity In Today's Session - Ardelyx (NASDAQ:ARDX), Blueprint Medicines...
Benzinga· 6 hours ago...Open Interest Volume MRK CALL SWEEP BEARISH 05/24/24 $133.00 $28.5K 477 2.1K INSM CALL SWEEP BULLISH 07/19/24 $45.00 $34.5K 20.0K 978 MRNA CALL SWEEP BEARISH 06/21/24 $130.00 $121.4K 4.0K 389 IQV CALL SWEEP BEARISH 06/21/24 $240.00 $32.3K 661 310 BPMC CALL TRADE BULLISH 06/21...
Company News For May 13, 2024
Zacks via Yahoo Finance· 4 days agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine....
Leaked Video of Mark Zuckerberg Discussing Vaccines Omits Context
Snopes via Yahoo News· 1 day agoMarketWatch, 15 July 2020, https://www.marketwatch.com/story/moderna- stock...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 5 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine ...
Post-pandemic problems: These stocks are still down more than 50 percent from their Covid highs
Bankrate via AOL· 2 days agoIts shares traded as low as $3.55 in December 2022. Covid high stock price: $376.83 Current stock...